Regs.gov: Agency for Toxic Substances and Disease Registry

ATSDR Substance Nominations for Toxicological Profiles

The Agency for Toxic Substances and Disease Registry (ATSDR) is seeking public nominations for substances to be evaluated for upcoming toxicological profiles. This notice opens a comment period for interested parties to suggest substances and provide rationale, with comments due by May 18, 2026.

ATSDR Toxicological Profile Public Comment Period

The Agency for Toxic Substances and Disease Registry (ATSDR) is providing a public comment period for its toxicological profiles. Interested parties can submit comments and attachments through the Regulations.gov portal. The deadline for submitting comments is May 18, 2026.

ATSDR Extends Comment Period for Draft Toxicological Profiles

The Agency for Toxic Substances and Disease Registry (ATSDR) has extended the public comment period for five draft toxicological profiles. The deadline for submitting comments has been moved to February 13, 2025.

ATSDR Notice 2025-23599

The Agency for Toxic Substances and Disease Registry (ATSDR) issued a notice regarding a public comment period that concluded on February 23, 2026. This notice pertains to a specific document identified by ATSDR-2025-23599. Further details on the subject matter are available via the provided URL.

ATSDR Tox Profile for Carbon Disulfide

The Agency for Toxic Substances and Disease Registry (ATSDR) has posted a Toxicological Profile for Carbon Disulfide. This document provides health information concerning exposure to this chemical.

ATSDR Tox Profile for CDDs

The Agency for Toxic Substances and Disease Registry (ATSDR) has posted a Toxicological Profile for CDDs. This document provides health information concerning environmental agents and is intended for public health and environmental professionals.

ATSDR Tox Profile for Benzene

The Agency for Toxic Substances and Disease Registry (ATSDR) has posted a final toxicological profile for Benzene. This document provides comprehensive health information on the substance, intended for public health and healthcare professionals.